Summary:
An Austrian university provides a core bio-laboratory facility for a wide range of collaborations (technical coop. agreements, research cooperation agreements or commercial agreements). The department can be used for the development, testing and validation of existing and new devices and reagents, with focus on life sciences, in vitro diagnostics, point-of-care and microfluidic systems. The research facility is aimed at companies interested in applied biomedical sciences.
Description:
The Austrian university is specialised in testing, validation and establishment of new diagnostic test systems. By using comparative measurements with human sample material in the low, normal and high reference range, it is possible to correlate new test systems with measured values from standardised laboratory analysis devices in the entire reference or measurement range. In this way, targeted optimisation of existing and new methods in the field of point-of-care testing can be achieved.
The offer in this field is unique and the university can look back to the successful acquisition and implementation of projects in basic and applied research as well as expertise in preanalytics, point-of-care systems and e-health.
The necessary infrastructure and qualified personnel for the analysis of human material, cell lines and bacterial cultures ensure processing based on current guidelines and applicable regulations. Thus, the precision of the test results as well as patient safety can be guaranteed.
Reference and stability tests of reagents for companies as well as patient sample measurements for clinical studies are also offered. The university is already involved in ongoing cooperations with two worldwide leading manufacturers of reagents for haemostaseology as well as allergy and autoimmune diagnostics, and two research institutes of Austrian hospitals.
This wide range of services not only supports companies in the development of high-quality and reliable medical products, but at the same time increases the accuracy of patient diagnostics.
The technology offer provider is interested in:
1. Technical cooperation agreements with manufacturers of in vitro diagnostic, point-of-care medical devices or the life science sector which are in need of reference testing and validation for their products in development.
2. Research cooperation agreements with other research institutes which do not have the infrastructure or personell to perform specific experiments for their studies.
3. Commercial agreements with technical assistance with companies active in medical diagnostics which want to re-evaluate testing protocols or stability of reagents.
Type (e.g. company, R&D institution…), field of industry and Role of Partner Sought:
Manufacturers of in vitro diagnostics, lab-on-a-chip and point-of-care systems which require reference tests for comparison with established methods.
Companies wishing to perform proficiency testing for their analytical instruments and/or reagents in the fields of haematology, haemostaseology, immunology, clinical chemistry, microbiology, histology and molecular biology.
Research institutions that require measurements in the fields of haematology, haemostaseology, immunology, clinical chemistry, microbiology, histology and molecular biology for their research projects and do not have the infrastructure or the technical and human resources to perform the required measurements.
Task to be performed by the Partner
The partner should provide at least a basic plan (workpackage(-s) and milestone(-s)) of the tasks that should be performed at the lab.
The partner should provide necessary technical or medical background information to perform the experiments and the data analysis at a high-quality level.
The partners need to supply financial support for necessary equipment (contributions in kind are also possible) and personnel costs.
Communication between the partners should be open and mutual and take place regularly for the cooperation to be of bilateral benefit and enable an exchange of know-how. Moreover, it should in principle be possible to include the gained knowledge into the existing teaching program of the university.
Stage of Development:
Under development/lab tested
Comments Regarding Stage of Development:
Currently, the performance of a microfluidic system for hematological analysis is tested with whole blood. Two other ongoing cooperations include the testing of autoimmune antibodies and hepatitis serology for a clinical study, as well as stability testing of reagents and preparation of samples for hemostaseology measurements.
IPR Status:
Secret Know-how,Design Rights,Exclusive Rights,Copyright
External code:
TOAT20211126001
